BRIEF-Aequus advances clinical development of Transdermal Aripiprazole Patch

Mon Oct 17, 2016 9:14am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Oct 17 (Reuters) - Aequus Pharmaceuticals Inc

* Aequus advances clinical development of Transdermal Aripiprazole Patch

* Upon approval of CTA, Co plans to initiate repeat dose, 28-day safety, study of Aripiprazole Transdermal Patches in late 2016 Source text for Eikon: Further company coverage: